Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends


Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

A roundup of regulatory activity around the country

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Women workers were more adversely impacted by the pandemic and the recession.
Apr 2022

Positive Marijuana Drug Screenings Reach All Time High

Quest Diagnostics reports increased positivity rates for marijuana in employee drug screenings.
Apr 2022

FDA Authorizes Second COVID-19 Booster Dose for Special Populations

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.
Apr 2022

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020
1 2 3 4